{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:14:54Z","timestamp":1791296094022,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2008,6,30]],"date-time":"2008-06-30T00:00:00Z","timestamp":1214784000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s00415-008-0929-0","type":"journal-article","created":{"date-parts":[[2008,6,24]],"date-time":"2008-06-24T11:50:36Z","timestamp":1214308236000},"page":"1400-1404","source":"Crossref","is-referenced-by-count":122,"title":["A natural history study of late onset spinal muscular atrophy types 3b and 4"],"prefix":"10.1007","volume":"255","author":[{"given":"S.","family":"Piepers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. H.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Brugman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Scheffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ruiterkamp-Versteeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. G.","family":"Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. G.","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.-L.","family":"Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H. J.","family":"Wokke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,30]]},"reference":[{"key":"929_CR1","doi-asserted-by":"crossref","unstructured":"The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I\u2013II Study Group. Arch Neurol 53:141\u2013147","DOI":"10.1001\/archneur.1996.00550020045014"},{"key":"929_CR2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.ejhg.5201320","volume":"13","author":"Brahe","year":"2005","unstructured":"Brahe C, Vitali T, Tiziano FD, Angelozzi C, Pinto AM, Borgo F, Moscato U, Bertini E, Mercuri E, Neri G (2005) Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients. Eur J Hum Genet 13:256\u2013259","journal-title":"Eur J Hum Genet"},{"key":"929_CR3","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","volume":"12","author":"Brichta","year":"2003","unstructured":"Brichta L, Hofmann Y, Hahnen E, Siebzehnrubl FA, Raschke H, Blumcke I, Eyupoglu IY, Wirth B (2003) Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet 12:2481\u20132489","journal-title":"Hum Mol Genet"},{"key":"929_CR4","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ana.20836","volume":"59","author":"Brichta","year":"2006","unstructured":"Brichta L, Holker I, Haug K, Klockgether T, Wirth B (2006) In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate. Ann Neurol 59:970\u2013975","journal-title":"Ann Neurol"},{"key":"929_CR5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/mus.880040304","volume":"4","author":"Brooke","year":"1981","unstructured":"Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ (1981) Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve 4:186\u2013197","journal-title":"Muscle Nerve"},{"key":"929_CR6","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1164\/ajrccm.167.9.950","volume":"167","author":"Brooks","year":"2003","unstructured":"Brooks D, Solway S, Gibbons WJ (2003) ATS statement on six-minute walk test. Am J Respir Crit Care Med 167:1287","journal-title":"Am J Respir Crit Care Med"},{"key":"929_CR7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.2004-0668","volume":"114","author":"Chung","year":"2004","unstructured":"Chung BH, Wong VC, Ip P (2004) Spinal muscular atrophy: survival pattern and functional status. Pediatrics 114:548\u2013553","journal-title":"Pediatrics"},{"key":"929_CR8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ana.20523","volume":"58","author":"Escolar","year":"2005","unstructured":"Escolar DM, Buyse G, Henricson E, Leshner R, Florence J, Mayhew J, Tesi- Rocha C, Gorni K, Pasquali L, Patel KM, McCarter R, Huang J, Mayhew T, Bertorini T, Carlo J, Connolly AM, Clemens PR, Goemans N, Iannaccone ST, Igarashi M, Nevo Y, Pestronk A, Subramony SH, Vedanarayanan VV, Wessel H (2005) CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy Ann Neurol 58:151\u2013155","journal-title":"Ann Neurol"},{"key":"929_CR9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"Feldkotter","year":"2002","unstructured":"Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B (2002) Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 70:358\u2013368","journal-title":"Am J Hum Genet"},{"key":"929_CR10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/bbrc.1995.2135","volume":"213","author":"Gennarelli","year":"1995","unstructured":"Gennarelli M, Lucarelli M, Capon F, Pizzuti A, Merlini L, Angelini C, Novelli G, Dallapiccola B (1995) Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem Biophys Res Commun 213:342\u2013348","journal-title":"Biochem Biophys Res Commun"},{"key":"929_CR11","doi-asserted-by":"crossref","unstructured":"Great Lake ALS Study Group (2003) A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis Neurology 61:1503\u20131507","DOI":"10.1212\/01.WNL.0000095961.66830.03"},{"key":"929_CR12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.nmd.2006.12.001","volume":"17","author":"Kaufmann","year":"2007","unstructured":"Kaufmann P, Muntoni F (2007) Issues in SMA clinical trial design. The International Coordinating Committee (ICC) for SMA Subcommittee on SMA Clinical Trial Design. Neuromuscul Disord 17:499\u2013505","journal-title":"Neuromuscul Disord"},{"key":"929_CR13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"Lefebvre","year":"1995","unstructured":"Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155\u2013165","journal-title":"Cell"},{"key":"929_CR14","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/515465","volume":"60","author":"McAndrew","year":"1997","unstructured":"McAndrew PE, Parsons DW, Simard LR, Rochette C, Ray PN, Mendell JR, Prior TW, Burghes AH (1997) Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 60:1411\u20131422","journal-title":"Am J Hum Genet"},{"key":"929_CR15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","volume":"32","author":"McHorney","year":"1994","unstructured":"McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD (1994) The MOS 36- item Short-Form Health Survey (SF- 36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups Med Care 32:40\u201366","journal-title":"Med Care"},{"key":"929_CR16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","volume":"2","author":"Munsat","year":"1992","unstructured":"Munsat TL, Davies KE (1992) International SMA consortium meeting. (26\u201328 June 1992, Bonn, Germany) Neuromuscul Disord 2:423\u2013428","journal-title":"Neuromuscul Disord"},{"key":"929_CR17","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.nmd.2007.05.009","volume":"17","author":"O\u2019hagen","year":"2007","unstructured":"O\u2019hagen JM, Glanzman AM, McDermott MP, Ryan PA, Flickinger J, Quigley J, Riley S, Sanborn E, Irvine C, Martens WB, Annis C, Tawil R, Oskoui M, Darras BT, Finkel RS, De V (2007) An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients. Neuromuscul Disord 17:693\u2013697","journal-title":"Neuromuscul Disord"},{"key":"929_CR18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000052118","volume":"45","author":"Rudnik-Schoneborn","year":"2001","unstructured":"Rudnik-Schoneborn S, Hausmanowa- Petrusewicz I, Borkowska J, Zerres K (2001) The predictive value of achieved motor milestones assessed in 441 patients with infantile spinal muscular atrophy types II and III. Eur Neurol 45:174\u2013181","journal-title":"Eur Neurol"},{"key":"929_CR19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.47.4.973","volume":"47","author":"Russman","year":"1996","unstructured":"Russman BS, Buncher CR, White M, Samaha FJ, Iannaccone ST (1996) Function changes in spinal muscular atrophy II and III. The DCN\/SMA Group. Neurology 47:973\u2013976","journal-title":"Neurology"},{"key":"929_CR20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nurx.2006.01.010","volume":"3","author":"Sumner","year":"2006","unstructured":"Sumner CJ (2006) Therapeutics development for spinal muscular atrophy. NeuroRx 3:235\u2013245","journal-title":"NeuroRx"},{"key":"929_CR21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","volume":"54","author":"Sumner","year":"2003","unstructured":"Sumner CJ, Huynh TN, Markowitz JA, Perhac JS, Hill B, Coovert DD, Schussler K, Chen X, Jarecki J, Burghes AH, Taylor JP, Fischbeck KH (2003) Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol 54:647\u2013654","journal-title":"Ann Neurol"},{"key":"929_CR22","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.20473","volume":"57","author":"Swoboda","year":"2005","unstructured":"Swoboda KJ, Prior TW, Scott CB, McNaught TP, Wride MC, Reyna SP, Bromberg MB (2005) Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann Neurol 57:704\u2013712","journal-title":"Ann Neurol"},{"key":"929_CR23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.ejhg.5200210","volume":"6","author":"Taylor","year":"1998","unstructured":"Taylor JE, Thomas NH, Lewis CM, Abbs SJ, Rodrigues NR, Davies KE, Mathew CG (1998) Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy. Eur J Hum Genet 6:467\u2013474","journal-title":"Eur J Hum Genet"},{"key":"929_CR24","unstructured":"Tomaszewicz K, Kang P, Wu BL (2005) Detection of homozygous and heterozygous SMN deletions of spinal muscular atrophy in a single assay with multiplex ligation-dependent probe amplification Beijing Da Xue Xue Bao 37:55\u201357"},{"key":"929_CR25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/01.wnl.0000231139.26253.d0","volume":"67","author":"Weihl","year":"2006","unstructured":"Weihl CC, Connolly AM, Pestronk A (2006) Valproate may improve strength and function in patients with type III\/ IV spinal muscle atrophy. Neurology 67:500\u2013501","journal-title":"Neurology"},{"key":"929_CR26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","volume":"119","author":"Wirth","year":"2006","unstructured":"Wirth B, Brichta L, Schrank B, Lochmuller H, Blick S, Baasner A, Heller R (2006) Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number Hum Genet 119:422\u2013428","journal-title":"Hum Genet"},{"key":"929_CR27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","volume":"52","author":"Zerres","year":"1995","unstructured":"Zerres K, Rudnik-Schoneborn S (1995) Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol 52:518\u2013523","journal-title":"Arch Neurol"},{"key":"929_CR28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-510X(96)00284-5","volume":"146","author":"Zerres","year":"1997","unstructured":"Zerres K, Rudnik-Schoneborn S, Forrest E, Lusakowska A, Borkowska J, Hausmanowa-Petrusewicz I (1997) A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients J Neurol Sci 146:67\u201372","journal-title":"J Neurol Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-0929-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-008-0929-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-0929-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:08:17Z","timestamp":1559056097000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-008-0929-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,30]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["929"],"URL":"https:\/\/doi.org\/10.1007\/s00415-008-0929-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,30]]}}}